Work

Data Supplement from Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Year: 2023

Type: other

Abstract: Supplemental Figure 1. Details about genetically engineered mouse model, with gross tumor lesions present in lung followed about negative FGFR2 IHC (control) and before/after BGJ-398 treatment.

DOI: 10.1158/0008-5472.22401374.v1

Authors: Jeremy H. Tchaicha, Esra A. Akbay, Abigail Altabef, Oliver R. Mikse, Eiki Kikuchi, Kevin Rhee, Rachel G. Liao, Roderick T. Bronson, Lynette M. Sholl, Matthew Meyerson, Peter S. Hammerman, Kwok-Kin Wong

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361847781

Cites:

Cited by:

Related to: 10